ADAGE CAPITAL PARTNERS GP, L.L.C. – Novo Nordisk A/S Transaction History
ADAGE CAPITAL PARTNERS GP, L.L.C. portfolio value:
$38.68M
portfolio value
ADAGE CAPITAL PARTNERS GP, L.L.C. quarter portfolio value change:
-10.59%
quarter
Novo Nordisk A/S 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -22.16% | -110.53K shares | -16.89M | $99.63 | 388.27K |
Q2 2022 | share | Decrease | -10.77% | -60.19K shares | -6.49M | $111.43 | 498.80K |
Q1 2022 | share | Increase | +6.48% | 34K shares | 3.27M | $111.05 | 559K |
Q4 2021 | share | Increase | 0.00% | 525K shares | 58.8M | $111.45 | 525K |
Q4 2020 | share | Decrease | -100.00% | -100K shares | -6.94M | $68.52 | 0 |
Q3 2020 | share | Decrease | -50.00% | -100K shares | -6.15M | $68.1 | 100K |
Q2 2020 | share | Decrease | -50.00% | -200K shares | -10.98M | $63.73 | 200K |
Q1 2020 | share | Decrease | -50.00% | -400K shares | -22.22M | $58.59 | 400K |
Q4 2019 | share | Decrease | -27.27% | -300K shares | -10.56M | $55.56 | 800K |
Q3 2019 | share | Decrease | -31.25% | -500K shares | -24.79M | $49.63 | 1.1M |
Q2 2019 | share | Increase | +131.88% | 910K shares | 45.57M | $48.57 | 1.6M |
Q1 2019 | share | Decrease | -20.23% | -175K shares | -3.75M | $49.78 | 690K |
Q4 2018 | share | Increase | +73.00% | 365K shares | 16.28M | $43.17 | 865K |
Q3 2018 | share | Increase | +66.67% | 200K shares | 9.73M | $44.17 | 500K |
Q2 2018 | share | Decrease | -40.00% | -200K shares | -10.78M | $43.22 | 300K |
Q1 2018 | share | Decrease | -28.57% | -200K shares | -12.94M | $46.15 | 500K |
Q4 2017 | share | Decrease | -12.50% | -100K shares | -951K | $49.61 | 700K |
Q3 2017 | share | Increase | +14.29% | 100K shares | 8.49M | $44.5 | 800K |
Q2 2017 | share | Increase | +600.00% | 600K shares | 26.59M | $39.35 | 700K |
Q1 2017 | share | Increase | 0.00% | 100K shares | 3.42M | $31.45 | 100K |